Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas

p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen.

Anticancer research·2001

Serum allopregnanolone in women with postpartum "blues".

Obstetrics and gynecology·2001

The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000

Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000

Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000

Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Cancer·2026

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Cancer·2026

Outcome after first relapse post-immunochemotherapy in older adults with Philadelphia-negative B-cell acute lymphoblastic leukemia: A GRAALL study.

Cancer·2026

Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation-The Peachtree Consensus.

Cancer·2026

Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer.

Cancer·2026

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial.

Cancer·2026

Clinical Trial Components of NIH Career Development Awards: Supporting the Nation's Future Trialists.

medRxiv : the preprint server for health sciences·2026

Development of a nodal burden-extranodal extension classification for pathological nodal staging in oral cavity squamous cell carcinoma.

Oral oncology·2026

New Progress in Pathological Classification and Treatment of Intracranial Chordoma.

Journal of visualized experiments : JoVE·2026

One patient with synchronous multiple primary colon cancers which is easy to miss: a case report.

Frontiers in surgery·2026

Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial.

Nature medicine·2026

Verification of human nucleotide sequence reagents and cell line identities in original circRNA articles published in high impact factor journals.

RNA (New York, N.Y.)·2026

Related Experiment Videos

Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas

Related Concept Videos

p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen.

Serum allopregnanolone in women with postpartum "blues".

The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study.

Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.

Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group.

Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations.

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Outcome after first relapse post-immunochemotherapy in older adults with Philadelphia-negative B-cell acute lymphoblastic leukemia: A GRAALL study.

Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation-The Peachtree Consensus.

Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer.

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial.

Clinical Trial Components of NIH Career Development Awards: Supporting the Nation's Future Trialists.

Development of a nodal burden-extranodal extension classification for pathological nodal staging in oral cavity squamous cell carcinoma.

New Progress in Pathological Classification and Treatment of Intracranial Chordoma.

One patient with synchronous multiple primary colon cancers which is easy to miss: a case report.

Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial.

Verification of human nucleotide sequence reagents and cell line identities in original circRNA articles published in high impact factor journals.

Related Experiment Videos

Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas

Related Concept Videos

Related Articles